Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 8-K Event Executive or director change
  2. 4 Open-market sale CMO, Hematology sold 1,925 shares at an average $354.97 ($683,323)
  3. 4 Open-market sale Global Head of R&D sold 455 shares at $362.48 ($164,930)
  4. 4 Open-market sale CFO & Chief Strategy Officer sold 446 shares at $365.00 ($162,790)
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. 4 Grant or award Director acquired 7,800 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 146,250 shares (grant or award)
  10. 4 Grant or award Director acquired 39,000 shares (grant or award)
  11. 4 Open-market sale President, COO & GM China sold 1,156 shares at $330.93 ($382,551)
  12. 4 Open-market sale Global Head of R&D sold 802 shares at $331.15 ($265,583)
  13. 4 Open-market sale CMO, Hematology sold 469 shares at $325.66 ($152,733)
  14. 4 Open-market sale CFO & Chief Strategy Officer sold 486 shares at $325.89 ($158,383)
  15. 4 Grant or award Director acquired 7,800 shares (grant or award)
  16. 4 Grant or award Director acquired 7,800 shares (grant or award)
  17. 4 Grant or award Director acquired 7,800 shares (grant or award)
  18. 4 Grant or award Director acquired 7,800 shares (grant or award)
  19. 4 Grant or award Director acquired 7,800 shares (grant or award)
  20. 4 Grant or award Director acquired 7,800 shares (grant or award)

Page 35 of 64 · 1,278 filings